Horovitz David, Feng Changyong, Messing Edward M, Joseph Jean V
Endourology and Minimally Invasive Surgery, Department of Urology, University of Rochester Medical Center, Rochester, NY, USA.
Department of Biostatistics and Computational Biology, University of Rochester Medical Center, Rochester, NY, USA.
J Robot Surg. 2017 Dec;11(4):447-454. doi: 10.1007/s11701-017-0678-0. Epub 2017 Jan 24.
Robot-assisted radical prostatectomy (RARP) may be performed via an extraperitoneal (eRARP) or transperitoneal (tRARP) approach. There are no published studies comparing these two methods in patients with a history of prior inguinal hernia repair with mesh (IHRm), but the latter is often advocated in this setting. A retrospective review of patients who underwent RARP with prior IHRm who had a minimum follow-up of 3 months from July 1, 2003 to December 31, 2014 was undertaken. Of 2927 patients who underwent RARP for primary treatment of adenocarcinoma of the prostate, 286 patients had a clear history of IHRm. Of these, 116 patients underwent eRARP and 170 patients underwent tRARP. No differences were noted between the groups with respect to age, body mass index or American Society of Anesthesiology score. Patients in the tRARP group had higher D'Amico risk classification scores (p < 0.0001) and as such, underwent less nerve-sparing procedures (p < 0.0001) and had a higher rate of concomitant pelvic lymph node dissections (p < 0.0001). The tRARP group had a higher incidence of laparoscopic and bilateral IHRm. On univariate analysis, EBL was lower in the tRARP group (172.41 vs. 201.98, p = 0.05) but all other parameters were similar. After controlling for covariates using regression analysis with model selection, a trend was noted towards lower operating room time in the tRARP group (p = 0.0624) but no other differences were noted. The presence of prior IHRm does not seem to be a contraindication to eRARP. OR time may be lower with tRARP (trend) but all other quality indicators studied were similar.
机器人辅助根治性前列腺切除术(RARP)可通过腹膜外(eRARP)或经腹(tRARP)入路进行。目前尚无已发表的研究比较这两种方法用于有既往腹股沟疝补片修补术(IHRm)病史患者的情况,但在这种情况下通常提倡采用后者。我们对2003年7月1日至2014年12月31日期间接受RARP且有既往IHRm病史、至少随访3个月的患者进行了回顾性研究。在2927例因前列腺腺癌接受RARP初次治疗的患者中,286例有明确的IHRm病史。其中,116例患者接受了eRARP,170例患者接受了tRARP。两组在年龄、体重指数或美国麻醉医师协会评分方面未发现差异。tRARP组患者的达米科风险分类评分较高(p<0.0001),因此,进行保留神经手术的比例较低(p<0.0001),同时进行盆腔淋巴结清扫的比例较高(p<0.0001)。tRARP组腹腔镜及双侧IHRm的发生率较高。单因素分析显示,tRARP组的估计失血量较低(172.41对201.98,p=0.05),但所有其他参数相似。在使用模型选择的回归分析控制协变量后,发现tRARP组的手术时间有缩短趋势(p=0.0624),但未发现其他差异。既往有IHRm病史似乎并非eRARP的禁忌证。tRARP的手术时间可能较短(有趋势),但所研究的所有其他质量指标相似。